Proteasome inhibitor-induced model of Parkinson's disease
- 21 July 2006
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 60 (2), 243-247
- https://doi.org/10.1002/ana.20936
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neuronsAnnals of Neurology, 2006
- Reproducible nigral cell loss after systemic proteasomal inhibitor administration to ratsAnnals of Neurology, 2006
- The proteasomal inhibition model of Parkinson's disease: “Boon or bust”?Annals of Neurology, 2006
- Lack of nigrostriatal pathology in a rat model of proteasome inhibitionAnnals of Neurology, 2006
- Proteasome inhibition and Parkinson's disease modelingAnnals of Neurology, 2006
- Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeysAnnals of Neurology, 2006
- Protein aggregation in the pathogenesis of familial and sporadic Parkinson's diseaseNeurobiology of Aging, 2006
- Pathogenetic mechanisms of parkin in Parkinson's diseaseThe Lancet, 2004
- Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's diseaseAnnals of Neurology, 2004
- Ubiquitination of α-Synuclein in Lewy Bodies Is a Pathological Event Not Associated with Impairment of Proteasome FunctionPublished by Elsevier BV ,2003